CETP inhibitor anacetrapib downregulates both LDL receptor and PCSK9 expression in cultured liver cells through a SREBP dependent mechanism

Authors
Publication date
1 January 2013
Publisher
'Ovid Technologies (Wolters Kluwer Health)'

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    University of Queensland eSpace

    redirect
    oaioai:espace.library.uq.edu.au:U...
    Last time updated on 19/04/2019